000 | 01621 a2200493 4500 | ||
---|---|---|---|
005 | 20250516095248.0 | ||
264 | 0 | _c20121113 | |
008 | 201211s 0 0 eng d | ||
022 | _a0391-1977 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSmacchia, M P | |
245 | 0 | 0 |
_aA case of GH deficiency and beta-thalassemia. _h[electronic resource] |
260 |
_bMinerva endocrinologica _cJun 2012 |
||
300 |
_a201-9 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 |
_aAsthenia _xetiology |
650 | 0 | 4 | _aBlood Transfusion |
650 | 0 | 4 |
_aCardiovascular Agents _xtherapeutic use |
650 | 0 | 4 | _aChelation Therapy |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xdrug therapy |
650 | 0 | 4 |
_aDwarfism _xdrug therapy |
650 | 0 | 4 |
_aGrowth Hormone _xtherapeutic use |
650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
650 | 0 | 4 |
_aHuman Growth Hormone _xdeficiency |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypogonadism _xcomplications |
650 | 0 | 4 |
_aInsulin _xadministration & dosage |
650 | 0 | 4 |
_aIron Chelating Agents _xtherapeutic use |
650 | 0 | 4 |
_aIron Overload _xetiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMitral Valve Insufficiency _xetiology |
650 | 0 | 4 |
_aTestosterone _xtherapeutic use |
650 | 0 | 4 |
_aTricuspid Valve Insufficiency _xetiology |
650 | 0 | 4 | _aYoung Adult |
650 | 0 | 4 |
_abeta-Thalassemia _xcomplications |
700 | 1 | _aMercuri, V | |
700 | 1 | _aAntonetti, L | |
700 | 1 | _aBassotti, G | |
700 | 1 | _aD'Amico, T | |
700 | 1 | _aPietrobono, D | |
700 | 1 | _aGargiulo, P | |
773 | 0 |
_tMinerva endocrinologica _gvol. 37 _gno. 2 _gp. 201-9 |
|
999 |
_c21859119 _d21859119 |